Delivery Order SPE2DB22D2007-SPE2DB24FJ3UC

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The award is a firm fixed price delivery order for Belbuca 450 mcg film in 60-count packages, with a ceiling value of $1,534.60 and a completion date of March 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,148.61 delivery order is for the supply of BELBUCA 450 MCG FILM 60S, a pharmaceutical product. The contract has a firm fixed price and is set to expire on September 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Belbuca 600 mcg film, a prescription medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a 2-year period with a ceiling value of $1,312.29. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for up to $999,999,999.00 through December 2025 to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,453.96 firm fixed-price delivery order is for the supply of BELBUCA 300 MCG FILM 60S, a prescription medication. The award has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,064.64 firm fixed-price delivery order is for the supply of BELBUCA 450 MCG FILM 60S, a pharmaceutical product. The contract has an ultimate completion date of December 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award is for the delivery of Belbuca 600 MCG film in 60-count packages, with a ceiling value of $2,048.10. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,427.23, is a delivery order for the supply of BELBUCA 450 MCG FILM 60S, a pharmaceutical product. The contract has an ultimate completion date of April 1, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside for any...
This federal contract award, with ID SPE2DX15D3005|SPE2DX24F3PJM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,316.04 firm fixed-price delivery order covers the supply of the drug Belbuca 600 mcg film, with a completion date of February 9, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,961.75 firm fixed-price delivery order is for the supply of BELBUCA 450 MCG FILM 60S, a medication used for pain management. The contract has an ultimate completion date of June 18, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,119.61 firm fixed-price delivery order is for the supply of BELBUCA 600 MCG FILM 60S, a pain management pharmaceutical product. The contract has an ultimate completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ3UC
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide Belbuca 450 MCG film, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price of $4,296.29 and has an ultimate completion date of June 28, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 9/26/24, 9:25 AM